Bengaluru, Karnataka, 25th of June, 2025 : Medtronic, a global leader in medical technology, has announced the launch of the Micra™ AV2 and VR2, the world’s smallest leadless pacemakers, in India. These are designed to last longer, work better, and make life easier for patients with slow heart rhythms.
The Micra™ AV2 and VR2 are the latest innovations in the Medtronic Micra leadless pacemaker family. They do not have leads or require a chest incision, which helps avoid potential complications, like infections, that can happen with traditional pacemakers with leads. The Micra AV2 also has smart technology that adjusts to each person’s heartbeat, helping the heart stay in sync even when the person is moving around.
These new pacemakers are enhanced with extended battery longevity and streamlined implant procedures. They last longer with a median projected battery lifespan of 15.6 years for the Micra AV2 and 16.7 years for the Micra VR2, over 80% of patients will only need one for their whole life. They are also compatible with smartphone-enabled remote monitoring, which can help with care.
Chandrashekhar Jaiman, Director Cardiovascular at Medtronic India commented, “At Medtronic, our mission is to alleviate pain, restore health, and extend life. With the launch of the Micra AV2 and VR2 in India, we are proud to advance that mission by redefining what’s possible in cardiac care. These next-generation leadless pacemakers represent a significant leap forward—combining miniaturization with intelligent pacing technology to deliver a superior experience for both patients and clinicians. This innovation is especially meaningful in India, where the growing burden of cardiovascular disease calls for scalable, accessible, and clinically advanced solutions.”
Real-world data from global studies show that the Micra leadless pacemakers significantly reduce major complications by as much as 53% compared to traditional pacemakers. These leadless devices can help patients to recover from the procedure with minimal signs of a visible implant. With Micra AV2 and VR2, we are not only advancing the science of cardiac care but also reaffirming our commitment to engineering innovative, life-enhancing solutions for patients in India.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. All details contained in this release are for general awareness purposes only and do not constitute medical advice.
About The Author
More Stories
Bihar SIR : 66.16% Enumeration, Forms Collected; 15 More Days Left.
3 Out Of Every 4 Bihar Electors Have Submitted Their Numeration Forms 74.39% Enumeration Forms Collected.
DRI Foils Major Smuggling Bid, Seizes ₹35 Crore Worth Of Chinese Firecrackers In “Operation Fire Trail”.